Atlas Trials

A Study of Single or Repeated Doses of Glucagon in Participants With Diabetes

Clinical trial NCT02806973 · COMPLETED

Trial details

NCT number
NCT02806973
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Start date
2015-01-01
Primary completion
2015-04-01
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.